(Q22252805)

Dimensions Publication ID

Dimensions

1035364722

7 February 2023

Saud A. Sadiq

series ordinal

2

author given names

Saud A.

author last names

Sadiq

1 reference

Dimensions Publication ID

Dimensions

1035364722

Molecular Diagnosis and Therapy

7 February 2023

publication date

August 2009

0 references

published in

1 reference

Blocking effects of serum reactive antibodies induced by glatiramer acetate treatment in multiple sclerosis

Crossref

volume

13

0 references

issue

4

0 references

page(s)

225-244

0 references

cites work

1 reference

12 December 2020

Interleukin-6 is elevated in plasma in multiple sclerosis

1 reference

12 December 2020

Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis

1 reference

12 December 2020

IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients

1 reference

12 December 2020

Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications

1 reference

12 December 2020

APOE genotypes in Greek multiple sclerosis patients: no effect on the MS Severity Score

1 reference

12 December 2020

Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis

1 reference

12 December 2020

Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis

1 reference

12 December 2020

Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability

1 reference

12 December 2020

The measurement of antibodies binding to IFNβ in MS patients treated with IFNβ

1 reference

12 December 2020

Nitric oxide and blood-brain barrier integrity

1 reference

12 December 2020

Identification of molecular biomarkers for multiple sclerosis

1 reference

12 December 2020

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

1 reference

12 December 2020

Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels

1 reference

12 December 2020

Predictive markers for response to interferon therapy in patients with multiple sclerosis

1 reference

12 December 2020

Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis

1 reference

12 December 2020

Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses

1 reference

12 December 2020

MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity

1 reference

12 December 2020

Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy

1 reference

12 December 2020

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

12 December 2020

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients

1 reference

12 December 2020

Myelin oligodendrocyte glycoprotein antibodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations

1 reference

12 December 2020

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease

1 reference

12 December 2020

1 reference

12 December 2020

High CSF neurofilament heavy chain levels in neuromyelitis optica

1 reference

12 December 2020

Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.

1 reference

12 December 2020

Imaging neuronal and axonal degeneration in multiple sclerosis

1 reference

12 December 2020

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

1 reference

12 December 2020

Acute transverse myelitis with normal brain MRI : long-term risk of MS

1 reference

12 December 2020

Cerebrospinal fluid and serum protein levels of tumour necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and soluble interleukin-6 receptor (sIL-6R gp80) in multiple sclerosis patients

1 reference

12 December 2020

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

12 December 2020

A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease

1 reference

12 December 2020

No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis

1 reference

12 December 2020

Increased release of interleukin-12p40 in MS: association with intracerebral inflammation

1 reference

12 December 2020

Cerebrospinal fluid myelin basic protein as a prognostic marker in patients with head injury.

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group

1 reference

12 December 2020

Proteomic analysis of multiple sclerosis cerebrospinal fluid

1 reference

12 December 2020

Correlations between IL-4, IL-12 levels and CCL2, CCL5 levels in serum and cerebrospinal fluid of multiple sclerosis patients

1 reference

12 December 2020

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

12 December 2020

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

12 December 2020

Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course

1 reference

12 December 2020

Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.

1 reference

12 December 2020

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

1 reference

12 December 2020

Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.

1 reference

12 December 2020

Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein

1 reference

12 December 2020

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

1 reference

12 December 2020

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

1 reference

12 December 2020

Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis

1 reference

12 December 2020

Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.

1 reference

12 December 2020

The role of nitric oxide in multiple sclerosis

1 reference

12 December 2020

Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Plasma osteopontin levels in multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy

1 reference

12 December 2020

Neuropsychologic status in multiple sclerosis after treatment with glatiramer

1 reference

12 December 2020

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis

1 reference

12 December 2020

Cleavage of cystatin C is not associated with multiple sclerosis

1 reference

12 December 2020

Old suspects found guilty--the first genome profile of multiple sclerosis

1 reference

12 December 2020

Expression pattern of NOGO-A protein in the human nervous system

1 reference

12 December 2020

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis

1 reference

12 December 2020

In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo

1 reference

12 December 2020

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

1 reference

12 December 2020

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

1 reference

12 December 2020

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature

1 reference

12 December 2020

Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases

1 reference

12 December 2020

Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event

1 reference

12 December 2020

The importance of measuring IFNbeta bioactivity: monitoring in MS patients and the effect of anti-IFNbeta antibodies.

1 reference

12 December 2020

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele

1 reference

12 December 2020

Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis

1 reference

12 December 2020

Cortical demyelination and diffuse white matter injury in multiple sclerosis.

1 reference

12 December 2020

Cerebrospinal fluid proteome profile in multiple sclerosis

1 reference

12 December 2020

Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.

1 reference

12 December 2020

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

1 reference

12 December 2020

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

1 reference

12 December 2020

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

1 reference

12 December 2020

Changes in nitrite and nitrate (NO2-/NO3-) levels in cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.

1 reference

12 December 2020

The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes

1 reference

12 December 2020

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis

1 reference

12 December 2020

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

12 December 2020

Antibodies against light neurofilaments in multiple sclerosis patients

1 reference

12 December 2020

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

1 reference

12 December 2020

Inhibitor of neurite outgrowth in humans

1 reference

12 December 2020

The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis

1 reference

12 December 2020

A stop-codon mutation in the BRI gene associated with familial British dementia

1 reference

12 December 2020

The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production

1 reference

12 December 2020

The value of animal models for drug development in multiple sclerosis.

1 reference

12 December 2020

Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis

1 reference

12 December 2020

Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis

1 reference

12 December 2020

Interferon receptor expression in multiple sclerosis patients.

1 reference

12 December 2020

Interferon beta 1-b in verbal memory functioning of patients with relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Transplantation of human neural stem cells for spinal cord injury in primates.

1 reference

12 December 2020

Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b.

1 reference

12 December 2020

APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis

1 reference

12 December 2020

Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis

1 reference

12 December 2020

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS

1 reference

12 December 2020

High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease

1 reference

12 December 2020

Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis

1 reference

12 December 2020

A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination

1 reference

12 December 2020

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

1 reference

12 December 2020

Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases

1 reference

12 December 2020

Elevated osteopontin levels in active relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions

1 reference

12 December 2020

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

1 reference

12 December 2020

Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients

1 reference

12 December 2020

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

12 December 2020

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

12 December 2020

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.

1 reference

12 December 2020

Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury

1 reference

12 December 2020

Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis

1 reference

12 December 2020

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

1 reference

12 December 2020

TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.

1 reference

12 December 2020

Antimyelin antibodies with no progression to multiple sclerosis.

1 reference

12 December 2020

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

1 reference

12 December 2020

Subpial demyelination in the cerebral cortex of multiple sclerosis patients

1 reference

12 December 2020

Apolipoprotein E alleles as risk factors in Alzheimer's disease

1 reference

12 December 2020

Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis

1 reference

12 December 2020

Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera

1 reference

12 December 2020

Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy

1 reference

12 December 2020

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study

1 reference

12 December 2020

Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

1 reference

12 December 2020

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization

1 reference

12 December 2020

Cerebrospinal Fluid Myelin Basic Protein and Multiple Sclerosis

1 reference

12 December 2020

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

1 reference

12 December 2020

Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination

1 reference

12 December 2020

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

1 reference

12 December 2020

Nitric oxide as an activity marker in multiple sclerosis

1 reference

12 December 2020

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions

1 reference

12 December 2020

1 reference

12 December 2020

Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker

1 reference

12 December 2020

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis.

1 reference

12 December 2020

Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution

1 reference

12 December 2020

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

12 December 2020

Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.

1 reference

12 December 2020

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

1 reference

12 December 2020

MR correlates of cerebral atrophy in patients with multiple sclerosis.

1 reference

12 December 2020

Increased cerebrospinal fluid tau protein in multiple sclerosis

1 reference

12 December 2020

BRI2 (ITM2b) inhibits Abeta deposition in vivo

1 reference

12 December 2020

Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations

1 reference

12 December 2020

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis

1 reference

12 December 2020

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

1 reference

12 December 2020

Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study

1 reference

12 December 2020

The role of TRAIL/TRAIL receptors in central nervous system pathology

1 reference

12 December 2020

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

1 reference

12 December 2020

Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis

1 reference

12 December 2020

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

1 reference

12 December 2020

Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis

1 reference

12 December 2020

The neuropsychiatry of multiple sclerosis: a review of recent developments

1 reference

12 December 2020

Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry

1 reference

12 December 2020

Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.

1 reference

12 December 2020

Epidemiology and natural history of multiple sclerosis: new insights

1 reference

12 December 2020

Cerebrospinal fluid myelin basic protein immunoreactivity as an indicator of brain damage in children

1 reference

12 December 2020

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

1 reference

12 December 2020

Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology.

1 reference

12 December 2020

N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve

1 reference

12 December 2020

Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.

1 reference

12 December 2020

BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production

1 reference

12 December 2020

Multiple sclerosis: an immune or neurodegenerative disorder?

1 reference

12 December 2020

Cystatin C in cerebrospinal fluid and multiple sclerosis

1 reference

12 December 2020

Risk alleles for multiple sclerosis identified by a genomewide study

1 reference

12 December 2020

Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis.

1 reference

12 December 2020

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

1 reference

12 December 2020

Lack of association between antimyelin antibodies and progression to multiple sclerosis

1 reference

12 December 2020

Neurofilament and glial fibrillary acidic protein in multiple sclerosis

1 reference

12 December 2020

Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders.

1 reference

12 December 2020

The 14-3-3 protein in multiple sclerosis: a marker of disease severity

1 reference

12 December 2020

The impact of our genes: consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis

1 reference

12 December 2020

Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells

1 reference

12 December 2020

Extensive cortical remyelination in patients with chronic multiple sclerosis.

1 reference

12 December 2020

Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis

1 reference

12 December 2020

Cerebrospinal fluid markers in Creutzfeldt-Jakob disease

1 reference

12 December 2020

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.

1 reference

12 December 2020

Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.

1 reference

12 December 2020

A randomized clinical trial of valacyclovir in multiple sclerosis

1 reference

12 December 2020

Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist

1 reference

12 December 2020

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

1 reference

12 December 2020

Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls

1 reference

12 December 2020

Multiple sclerosis: advances in understanding, diagnosing, and treating the underlying disease.

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 reference

12 December 2020

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

1 reference

12 December 2020

Anti-IFN BAb and NAb antibodies: a minireview

1 reference

12 December 2020

Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.

1 reference

12 December 2020

Cerebrospinal fluid levels of brain specific proteins in optic neuritis

1 reference

12 December 2020

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders

1 reference

12 December 2020

Simultaneous measurement of 2':3' cyclic-nucleotide 3' phosphodiesterase and RNase activities in sera and spinal fluids of multiple sclerosis patients

1 reference

12 December 2020

Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis

1 reference

12 December 2020

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

1 reference

12 December 2020

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

1 reference

12 December 2020

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03256329

7 January 2021

inferred from DOI database lookup

Protection of research subjects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF03256329

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1007/BF03256329

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1035364722

0 references

Fatcat ID

release_4ln5d2pzljccbnszn2dn5vf2ly

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ln5d2pzljccbnszn2dn5vf2ly

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

19712003

1 reference

Consolidated OpenCitations Corpus – April 2017